Get started
CAPLIN POINT LABORATORIES LTD.CAPLIN POINT LABORATORIES LTD.CAPLIN POINT LABORATORIES LTD.

CAPLIN POINT LABORATORIES LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CAPLIPOINT chart


Full chart

CAPLIPOINT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪184.18 B‬ INR
Dividend yield (indicated)
0.21%
Price to earnings Ratio (TTM)
37.50
Basic EPS (TTM)
64.95 INR
Net income (FY)
‪4.57 B‬ INR
Revenue (FY)
‪16.77 B‬ INR
Shares float
‪20.32 M‬
Beta (1Y)
0.75

Employees


Employees (FY)
‪4.88 K‬
Change (1Y)
‪+3 K‬ +158.85%
Revenue / Employee (1Y)
‪3.43 M‬ INR
Net income / Employee (1Y)
‪936.28 K‬ INR

About CAPLIN POINT LAB LTD.


Sector
Health Technology
CEO
Sridhar Ganesan
Headquarters
Chennai
Website
caplinpoint.net
Founded
1990
ISIN
INE475E01026
FIGI
BBG000F1M880
Caplin Point Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It offers antibiotics, non-steroidal anti-inflammatory drugs (NSAIDS), ophthalmic, pain management, and anti-ulcer products. The company was founded on April 16, 1990 and is headquartered in Chennai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CAPLIPOINT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CAPLIPOINT is 2,395.00 INR — it has decreased by −1.42% in the past 24 hours. Watch CAPLIN POINT LABORATORIES LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange CAPLIN POINT LABORATORIES LTD. stocks are traded under the ticker CAPLIPOINT.
CAPLIPOINT stock has risen by 0.26% compared to the previous week, the month change is a 23.28% rise, over the last year CAPLIN POINT LABORATORIES LTD. has showed a 71.68% increase.
We've gathered analysts' opinions on CAPLIN POINT LABORATORIES LTD. future price: according to them, CAPLIPOINT price has a max estimate of 2,510.00 INR and a min estimate of 2,280.00 INR. Watch CAPLIPOINT chart and read a more detailed CAPLIN POINT LABORATORIES LTD. stock forecast: see what analysts think of CAPLIN POINT LABORATORIES LTD. and suggest that you do with its stocks.
CAPLIPOINT reached its all-time high on Dec 5, 2024 with the price of 2,486.65 INR, and its all-time low was 1,221.00 INR and was reached on Jun 4, 2024. View more price dynamics on CAPLIPOINT chart.
See other stocks reaching their highest and lowest prices.
CAPLIPOINT stock is 2.10% volatile and has beta coefficient of 0.75. Track CAPLIN POINT LABORATORIES LTD. stock price on the chart and check out the list of the most volatile stocks — is CAPLIN POINT LABORATORIES LTD. there?
Today CAPLIN POINT LABORATORIES LTD. has the market capitalization of ‪184.18 B‬, it has increased by 4.01% over the last week.
Yes, you can track CAPLIN POINT LABORATORIES LTD. financials in yearly and quarterly reports right on TradingView.
CAPLIN POINT LABORATORIES LTD. is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
CAPLIPOINT net income for the last quarter is ‪1.31 B‬ INR, while the quarter before that showed ‪1.24 B‬ INR of net income which accounts for 5.51% change. Track more CAPLIN POINT LABORATORIES LTD. financial stats to get the full picture.
CAPLIN POINT LABORATORIES LTD. dividend yield was 0.38% in 2023, and payout ratio reached 8.31%. The year before the numbers were 0.75% and 9.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 18, 2024, the company has ‪4.88 K‬ employees. See our rating of the largest employees — is CAPLIN POINT LABORATORIES LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CAPLIN POINT LABORATORIES LTD. EBITDA is ‪6.04 B‬ INR, and current EBITDA margin is 32.25%. See more stats in CAPLIN POINT LABORATORIES LTD. financial statements.
Like other stocks, CAPLIPOINT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CAPLIN POINT LABORATORIES LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CAPLIN POINT LABORATORIES LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CAPLIN POINT LABORATORIES LTD. stock shows the strong buy signal. See more of CAPLIN POINT LABORATORIES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.